Kerry Q3 Volumes Rise 4.1% as Protein Masking and Reformulation Drive Demand
Kerry Group delivered 4.1% volume growth in Q3 2026, widening EBITDA margins by 50 basis points despite a 0.6% revenue drop. Accelerating uptake of protein-masking and bio-fermentation systems highlights strong commercial momentum across nutritional beverage reformulation.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Tralee, Ireland — 22 October 2026 — Kerry Group reported a 4.1% volume increase for the third quarter of 2026, accelerating from earlier quarters to lift nine-month volume growth to 3.6%. The performance reflects sustained procurement demand for specialized taste, clean-label preservation, and nutritional reformulation solutions across food, beverage, and active nutrition sectors.
Reported group revenue contracted by 0.6% over the first nine months, constrained by adverse foreign exchange movements, portfolio disposals net of acquisitions, and lower net pricing passed through from raw material deflation. Despite top-line contraction, Kerry widened its EBITDA margin by 50 basis points. Management attributed the margin expansion to operational efficiencies delivered under the Accelerate 2.0 programme, alongside favorable product mix and operating leverage. The company maintained full-year 2026 guidance for constant-currency adjusted earnings per share growth of 6% to 10%.
Category performance demonstrated strong pull from high-protein formulations and functional beverages. Product developers expanding ready-to-drink (RTD) protein and botanical lines relied heavily on Kerry's enzyme-driven taste systems, protein-masking platforms, and Tastesense sugar and salt reduction technologies. In nutritional beverages, masking agents remain critical to resolving astringency and bitterness in formulations carrying elevated whey, pea, or collagen loads.
Regional volume patterns varied considerably. APMEA led nine-month performance with 5.2% volume growth, driven by dairy, meat, and bakery applications, followed by the Americas at 4.0%. European volumes grew by just 0.7%, indicating measured order patterns among contract manufacturers navigating cautious retail demand, even as low-alcohol, high-protein, and reduced-sugar launches expanded.
What this means for Ireland
For Irish brand owners and contract packers, Kerry's margin expansion amid raw material deflation demonstrates that primary ingredient suppliers are capturing premium margins on specialized formulation aids rather than base bulk commodities. Irish sports nutrition brands reformulating RTDs or functional snacks must secure supply agreements for advanced masking agents and bio-fermentation preservatives to satisfy clean-label criteria monitored by the Food Safety Authority of Ireland (FSAI). With European volume growth subdued at 0.7%, domestic brand procurement leads possess immediate leverage to negotiate volume-tiered pricing on proprietary masking and botanical systems before annual contract cycles close for 2027.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.